
Sign up to save your podcasts
Or


This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
As obesity rates continue to rise in adults with type 1 diabetes, what can we do to combat this growing obstacle? Dr. John Buse speaks with an expert in the field, Dr. Elizabeth Selvin, about obesity in patients with type 1 diabetes and shares management strategies.
At the American College of Cardiology's 72nd Annual Scientific Session & Expo, cardiologists will gather to explore the latest advancements in the field. Joining us to share what you can expect to learn about statin intolerance at their upcoming session are Dr. Mary Katherine Cheeley and Dr. Kevin Maki.
New guidelines published by Obesity Canada take a deep dive into pharmacotherapy and feature the latest recommendations on comorbidities and decision tools. To better understand the impact of these guidelines, Dr. John Buse speaks with one of the guidelines authors, Dr. Sue Pedersen, a specialist in endocrinology and metabolism.
Since 2020, pediatricians have seen a rapid rise in new-onset type 1 diabetes in children. Is this due to the COVID-19 pandemic or an indirect consequence of it? To answer this question, Dr. Jane Kim, a pediatric endocrinologist at Rady Children's Hospital in San Diego, shares what kind of correlation she's seeing.
Emerging research details a rapid rise in type 1 diabetes in children amid the COVID-19 pandemic. But what's causing this to happen? To dive into why, Dr. Carol Wysham is joined by Dr. Jane Kim from the Rady Children's Hospital in San Diego.
How can we better communicate lifestyle changes and glucose monitoring levels with our diabetic patients? Dr. Claresa Levetan, an endocrinologist at Grand View Health in Lansdale, Pennsylvania, shares key communication strategies she uses with her patients.
Diabetes impacts around 40 million Americans and 25% of them don't even know they have it. Luckily, Diabetes Alert Day was created to spread awareness of this widespread disease. To help us understand this campaign, Dr. Claresa Levetan, an endocrinologist at Grand View Health in Lansdale, Pennsylvania, shares insights on the importance of Diabetes Alert Day.